Cantel Medical Corporation
CMD
CMD was delisted on the 1st of June, 2021.
145 hedge funds and large institutions have $1.1B invested in Cantel Medical Corporation in 2014 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 43 increasing their positions, 61 reducing their positions, and 15 closing their positions.
36% more call options, than puts
Call options by funds: $790K | Put options by funds: $583K
13% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 15
1% more funds holding
Funds holding: 144 → 145 (+1)
0% more capital invested
Capital invested by funds: $1.1B → $1.1B (+$1.91M)
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
30% less repeat investments, than reductions
Existing positions increased: 43 | Existing positions reduced: 61
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCA
Conestoga Capital Advisors
Wayne,
Pennsylvania
|
+$14.6M |
| 2 |
O
OppenheimerFunds
New York
|
+$6.16M |
| 3 |
Bank of New York Mellon
New York
|
+$6.11M |
| 4 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
+$4.79M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.97M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Northern Trust
Chicago,
Illinois
|
-$11.3M |
| 2 |
Morgan Stanley
New York
|
-$5.77M |
| 3 |
EARNEST Partners
Atlanta,
Georgia
|
-$4.75M |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$2.69M |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$2.37M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SCA
151
SAC Capital Advisors
Stamford,
Connecticut
| – | -$378K | -11,157 | Closed |
|
152
Jane Street
New York
| – | -$371K | -10,952 | Closed |
|
153
Tudor Investment Corp
Stamford,
Connecticut
| – | -$359K | -10,600 | Closed |
|
154
Nomura Holdings
Tokyo,
Japan
| – | -$354K | -10,422 | Closed |
|
|
SCM
155
Stevens Capital Management
Radnor,
Pennsylvania
| – | -$326K | -9,626 | Closed |
|
|
NI
156
Numeric Investors
Boston,
Massachusetts
| – | -$319K | -9,400 | Closed |
|
|
OAM
157
Origin Asset Management
London,
United Kingdom
| – | -$226K | -6,661 | Closed |
|
|
DTL
158
Dynamic Technology Lab
Singapore
| – | -$220K | -6,483 | Closed |
|
159
Citadel Advisors
Miami,
Florida
| – | -$113K | -3,432 | Closed |
|
|
TRCT
160
Tower Research Capital (TRC)
New York
| – | -$39K | -1,154 | Closed |
|
CMD Hedge Fund Activity: Q1 2014 in Review
145 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in Cantel Medical Corporation (CMD) for Q1 2014, worth a combined $1.1B — up 0.17% from $1.1B a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new CMD positions and 15 closed out — a net gain of 2 holders — while 43 added to existing stakes and 61 trimmed.
The largest buyer was Conestoga Capital Advisors, opening a new position worth an estimated $14.6M. The largest seller was Northern Trust, cutting an estimated $11.3M.
- 145 institutional investors held Cantel Medical Corporation (CMD) as of Q1 2014, up from 144 in Q4 2013.
- Funds reported $1.1B of Cantel Medical Corporation stock for Q1 2014, up 0.17% quarter-over-quarter.
- 17 funds opened new Cantel Medical Corporation positions in Q1 2014 and 15 closed out, a net change of +2 holders.
- The largest Cantel Medical Corporation buyer in Q1 2014 was Conestoga Capital Advisors, an estimated $14.6M added.
- The largest Cantel Medical Corporation seller in Q1 2014 was Northern Trust, an estimated $11.3M sold.
Based on aggregated 13F filings for Q1 2014.